A phase I study of LBH589 [panobinostat] in combination with gemcitabine in the treatment of solid tumors.

Trial Profile

A phase I study of LBH589 [panobinostat] in combination with gemcitabine in the treatment of solid tumors.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 24 Nov 2013

At a glance

  • Drugs Panobinostat (Primary) ; Gemcitabine
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Jul 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 01 May 2009 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.
    • 11 Mar 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top